Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.

Subjects

Subjects :

Antibodies, Monoclonal therapeutic use
Evidence-Based Medicine
Humans
Infliximab
Behcet Syndrome drug therapy
Immunosuppressive Agents therapeutic use
Tumor Necrosis Factor-alpha antagonists & inhibitors
Uveitis drug therapy

Details

Language :

English

ISSN :

1468-2079

Volume :

94

Issue :

3

Database :

MEDLINE

Journal :

The British journal of ophthalmology

Publication Type :

Editorial & Opinion

Accession number :

20215370

Full Text :

https://doi.org/10.1136/bjo.2009.176750